|
DNLI
|
Denali Therapeutics Inc.
|
0.26%
|
US
|
NASDAQ
|
|
ZLAB
|
Zai Lab Limited
|
0.24%
|
US
|
NASDAQ
|
|
IRWD
|
Ironwood Pharmaceuticals, Inc.
|
0.24%
|
US
|
NASDAQ
|
|
ARVN
|
Arvinas, Inc.
|
0.24%
|
US
|
NASDAQ
|
|
INSM
|
Insmed, Inc.
|
0.23%
|
US
|
NASDAQ
|
|
FATE
|
Fate Therapeutics, Inc.
|
0.23%
|
US
|
NASDAQ
|
|
PCRX
|
Pacira Pharmaceuticals, Inc.
|
0.22%
|
US
|
NASDAQ
|
|
GLPG
|
Galapagos NV
|
0.22%
|
US
|
NASDAQ
|
|
TCDA
|
Tricida, Inc.
|
0.21%
|
US
|
NASDAQ
|
|
RGNX
|
REGENXBIO Inc.
|
0.21%
|
US
|
NASDAQ
|
|
ITCI
|
Intra-Cellular Therapies Inc.
|
0.21%
|
US
|
NASDAQ
|
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
0.19%
|
US
|
NASDAQ
|
|
ESPR
|
Esperion Therapeutics, Inc.
|
0.19%
|
US
|
NASDAQ
|
|
EDIT
|
Editas Medicine, Inc.
|
0.19%
|
US
|
NASDAQ
|
|
VCYT
|
Veracyte, Inc.
|
0.18%
|
US
|
NASDAQ
|
|
INVA
|
Innoviva, Inc.
|
0.18%
|
US
|
NASDAQ
|
|
ALEC
|
Alector, Inc.
|
0.18%
|
US
|
NASDAQ
|
|
TBPH
|
Theravance Biopharma, Inc.
|
0.17%
|
US
|
NASDAQ
|
|
YMAB
|
Y-mAbs Therapeutics, Inc.
|
0.16%
|
US
|
NASDAQ
|
|
CHRS
|
Coherus BioSciences, Inc.
|
0.16%
|
US
|
NASDAQ
|